Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or North Dakota for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to North Dakota only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. North Dakota (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

William Noyes (NPI 1649382292)

Field	Value
Entity Type	Individual
Organization	William Noyes
Address	1451 44th Ave S
City	Grand Forks
State	ND
ZIP	58201
Taxonomy	Radiation Oncology Physician
NPI Enumerated	August 31, 2006

Payer Source	Total Paid
Medicare	$1.2M
Medicaid	$0

Key Findings

This provider’s Medicare revenue is highly concentrated: the top three Medicare codes — 78815, J9271, and A9552 — together account for 80.1% of total Medicare revenue. Individually those codes generate $567.2K (48.8%), $223.7K (19.2%), and $141.3K (12.1%) of Medicare revenue, respectively, making imaging and a single high-use drug code the primary drivers of the practice’s billing profile.

The code mix points to a practice centered on advanced oncologic imaging and integrated cancer care rather than being purely therapy-focused. High-revenue diagnostic imaging codes 78815 (PET/CT) and A9552 (FDG f-18 diagnostic dose) dominate the portfolio, while chemotherapy/immunotherapy billing appears through J9271 (pembrolizumab) at $223.7K, indicating the provider bills both imaging and systemic oncology drug administration in addition to radiation services.

Although the provider bills for radiation treatment and planning, those therapy codes are secondary in revenue: 77373 (SBRT technical component) produced $47.1K (4.0%), 77301 (IMRT) produced $39.9K (3.4%), and 77427 produced $9.1K (0.8%). This pattern suggests the practice delivers a full radiation oncology service line but generates most Medicare dollars from diagnostic imaging and radiopharmaceuticals rather than from procedure-dominant radiation billing.

On competitive standing, the provider is a national high-volume outlier for PET/CT imaging: 78815 ranks #253 of 6566 providers nationally (96th percentile; notably above typical national volume) and A9552 ranks #63 of 2411 providers nationally (97th percentile; notably above typical national volume). By contrast, J9271 ranks #1686 of 1841 providers nationally (8th percentile; typical, unremarkable volume), indicating that while imaging volume is well above peers, pembrolizumab administration is modest relative to the national peer set.

The payer mix is effectively single-payer Medicare: Total Medicare revenue is $1.2M while Total Medicaid revenue is none (no Medicaid billing on file). The lack of any Medicaid billing on file implies minimal to no direct revenue exposure to Medicaid managed care or fee-for-service Medicaid populations, which concentrates reimbursement risk and patient access on Medicare beneficiaries.

The practice shows long administrative tenure in federal programs, with NPI enumeration on 2006-08-31 (~20 years ago). That long enrollment window is consistent with an established local practice that has built sustained Medicare billing relationships over time.

Per-claim payment levels underscore resource intensity in imaging: 78815 reports an average paid/claim of $1189 and A9552 reports $286 avg paid/claim, supporting the observation that high-revenue, resource-intensive diagnostic studies are central to the provider’s revenue profile. These higher per-claim payments contribute materially to why imaging codes dominate overall Medicare revenue.

The broader procedural mix includes many lower-revenue, typical-volume oncology and infusion codes (examples: 99214 $13.2K, 96413 $11.6K, 77338 $10.8K), suggesting the practice offers ancillary oncology care and infusion services at modest volumes compared with its imaging workload. For payers or competitors assessing capacity, this indicates a practice that pairs very high imaging throughput with routine oncology and supportive care services rather than concentrating exclusively on high-volume radiation treatment delivery.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

37 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
78815	PET and CT scans are both standard imaging tools that allow doctors to evaluate the location and metabolic actions of tumors or cancer inside the body before beginning an active treatment regimen.…	480	$1,190	$567.2K
J9271	Injection, pembrolizumab, 1 mg	5,200	$40	$223.7K
A9552	Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries	490	$290	$141.3K
77373	This code represents the technical component of a procedure in which the provider performs stereotactic body radiation therapy. The therapy uses a three–dimensional coordinate system to locate small…	60	$810	$47.1K
77301	Intensity modulated radiotherapy (IMRT) uses advanced computer technology to deliver very precise radiation beams that target and destroy the cancerous cells while avoiding the surrounding healthy…	30	$1,480	$39.9K
77014	N/A	200	$100	$19.4K
J1439	Injection, ferric carboxymaltose, 1 mg	13,500	$1	$13.5K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	140	$100	$13.2K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	120	$100	$11.6K
77338	In this procedure, the provider participates in the design and construction of one or more multi–leaf collimator, MLC, devices for intensity modulated radiation therapy, IMRT. IMRT is a radiotherapy…	30	$370	$10.8K

Showing 1–10 of 37

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 37 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. North Dakota Distribution

William Noyes — 1 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — North Dakota

Full comparison — all codes billed, vs. state median

37 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J9271	2	10	19,710	$40	$850.8K
A9552	1	10	490	$290	$141.5K
77373	4	10	100	$820	$78.3K
J1439	4	10	24,750	$1	$61.8K
77014	11	10	900	$60	$57.8K
77301	11	10	60	$690	$41.6K
77427	14	10	160	$150	$28.5K
78815	1	30	70	$260	$27.1K
Q5110	2	10	76,320	$1	$19.9K
77336	5	10	290	$70	$17.4K

Showing 1–10 of 37

Related Providers

Other providers that share a Tax Identification Number (TIN) with William Noyes, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Anil Potti	ND	Hematology & Oncology Physician	$4.9M	$0
Marina Gilca	ND	Retina Specialist (Ophthalmology) Physician	$4.3M	$0
Jonathan Marshall	NY	Diagnostic Radiology Physician	$761.9K	$4.4K
Myles Mitsunaga	CA	Diagnostic Radiology Physician	$510.8K	$113.9K
Aaron Fortney	ND	Ophthalmology Physician	$561.1K	$0
Monte Leidenix	ND	Ophthalmology Physician	$553.3K	$0
Mark Sczepanski	ND	Ophthalmology Physician	$545.7K	$0
Rachel Ness	ND	Dermatology Physician	$539.5K	$0
Ikechukwu Onyeka	ND	Internal Medicine Physician	$486.7K	$0
Scott Marlowe	PA	Diagnostic Ultrasound Physician	$468.7K	$60

Nearby Providers

Other providers in the same ZIP code as William Noyes, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Development Homes Inc	ND	Community/Behavioral Health Agency	$0	$53.9M
Altru Health System	ND	Clinic/Center	$0	$29.7M
Altru Health System	ND	General Acute Care Hospital	$0	$18.7M
L.i.s.t.e.n. Inc	ND	Community/Behavioral Health Agency	$0	$9.4M
Peterson Medical Clinics, LLC	ND	Multi-Specialty Clinic/Center	$0	$8.8M
Edgewood Sartell LLC	ND	Assisted Living Facility	$0	$7.1M
Northeast Behavioral Health Clinic	ND	Mental Health Clinic/Center (Including Community Mental Health Center)	$0	$6.7M
Spectra Health	ND	Federally Qualified Health Center (FQHC)	$0	$5.5M
Little Miracles, Inc.	ND	Multi-Specialty Clinic/Center	$0	$5.5M
Valley Oral & Facial Surgery PC	ND	Oral and Maxillofacial Surgery Clinic/Center	$0	$4.5M

William Noyes — Billing Profile & Reimbursement Data

Sign up for William Noyes — Billing Profile & Reimbursement Data policy alerts

William Noyes — Billing Profile & Reimbursement Data

Sign up for William Noyes — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References